214 related articles for article (PubMed ID: 1967496)
1. Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells.
Applegate ML; Moore MM; Broder CB; Burrell A; Juhn G; Kasweck KL; Lin PF; Wadhams A; Hozier JC
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):51-5. PubMed ID: 1967496
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic analysis of the L5178Y/TK+/- leads to TK-/- mouse lymphoma mutagenesis assay system.
Hozier J; Sawyer J; Moore M; Howard B; Clive D
Mutat Res; 1981 Nov; 84(1):169-81. PubMed ID: 7329431
[TBL] [Abstract][Full Text] [Related]
3. Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells.
Clark LS; Hart DW; Vojta PJ; Harrington-Brock K; Barrett JC; Moore MM; Tindall KR
Mutagenesis; 1998 Sep; 13(5):427-34. PubMed ID: 9800187
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of mutations at the tk locus of L5178Y mouse-lymphoma cells induced by ethyl methanesulphonate and mitomycin C.
Davies MJ; Phillips BJ; Rumsby PC
Mutat Res; 1993 Dec; 290(2):145-53. PubMed ID: 7694105
[TBL] [Abstract][Full Text] [Related]
5. Loss of P53 heterozygosity is not responsible for the small colony thymidine kinase mutant phenotype in L5178Y mouse lymphoma cells.
Clark LS; Harrington-Brock K; Wang J; Sargent L; Lowry D; Reynolds SH; Moore MM
Mutagenesis; 2004 Jul; 19(4):263-8. PubMed ID: 15215324
[TBL] [Abstract][Full Text] [Related]
6. Sequence analysis of tka(-)-1 and tkb(+)-1 alleles in L5178Y tk+/- mouse-lymphoma cells and spontaneous tk-/- mutants.
Liechty MC; Rauchfuss HS; Lugo MH; Hozier JC
Mutat Res; 1993 Apr; 286(2):299-307. PubMed ID: 7681542
[TBL] [Abstract][Full Text] [Related]
7. High-resolution cytogenetic analysis of L5178Y TK+/- 3.7.2C cells: variation in chromosome 11 breakpoints among small-colony TK-/- mutants.
Hozier JC; Sawyer JR; Moore MM
Mutat Res; 1989 Oct; 214(2):195-9. PubMed ID: 2797025
[TBL] [Abstract][Full Text] [Related]
8. Mutant frequencies and loss of heterozygosity induced by N-ethyl-N-nitrosourea in the thymidine kinase gene of L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.
Chen T; Harrington-Brock K; Moore MM
Mutagenesis; 2002 Mar; 17(2):105-9. PubMed ID: 11880538
[TBL] [Abstract][Full Text] [Related]
9. Molecular aspects of chemical mutagenesis in L5178Y/tk +/- mouse lymphoma cells.
Clive D; Glover P; Applegate M; Hozier J
Mutagenesis; 1990 Mar; 5(2):191-7. PubMed ID: 2188074
[TBL] [Abstract][Full Text] [Related]
10. Comparison of chromosome aberration frequency and small-colony TK-deficient mutant frequency in L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.
Moore MM; Doerr CL
Mutagenesis; 1990 Nov; 5(6):609-14. PubMed ID: 2263219
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic distinction between the TK+ and TK- chromosomes in the L5178Y TK+/- 3.7.2C mouse-lymphoma cell line.
Hozier J; Sawyer J; Clive D; Moore M
Mutat Res; 1982 Dec; 105(6):451-6. PubMed ID: 7155165
[No Abstract] [Full Text] [Related]
12. Microarray analysis distinguishes differential gene expression patterns from large and small colony Thymidine kinase mutants of L5178Y mouse lymphoma cells.
Han T; Wang J; Tong W; Moore MM; Fuscoe JC; Chen T
BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S9. PubMed ID: 17118152
[TBL] [Abstract][Full Text] [Related]
13. The utilization of trifluorothymidine (TFT) to select for thymidine kinase-deficient (TK-/-) mutants from L5178Y/TK+/- mouse lymphoma cells.
Moore-Brown MM; Clive D; Howard BE; Batson AG; Johnson KO
Mutat Res; 1981 Oct; 85(5):363-78. PubMed ID: 6795499
[TBL] [Abstract][Full Text] [Related]
14. Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK +/- -3.7.2C mouse lymphoma cells.
DeMarini DM; Brock KH; Doerr CL; Moore MM
Mutat Res; 1987 Mar; 187(3):141-9. PubMed ID: 3821767
[TBL] [Abstract][Full Text] [Related]
15. Preliminary molecular analysis of the TK locus in L5178Y large- and small-colony mouse lymphoma cell mutants.
Cobb RR; Martin J; Korytynski E; Monteith L; Hughes TJ
Mutat Res; 1989 Aug; 226(4):253-8. PubMed ID: 2761566
[TBL] [Abstract][Full Text] [Related]
16. Procarbazine is a potent mutagen at the heterozygous thymidine kinase (tk +/-) locus of mouse lymphoma assay.
Clive D; Turner N; Krehl R
Mutagenesis; 1988 Mar; 3(2):83-7. PubMed ID: 3288842
[TBL] [Abstract][Full Text] [Related]
17. Use of DNA purified in situ from cells embedded in agarose plugs for the molecular analysis of tk-/- mutants recovered in the L5178Y tk+/- 3.7.2C mutagen assay system.
Applegate M; Juhn G; Liechty M; Moore M; Hozier J
Mutat Res; 1990 Sep; 245(1):55-9. PubMed ID: 2392130
[TBL] [Abstract][Full Text] [Related]
18. Do trifluorothymidine-resistant mutants of L5178Y mouse lymphoma cells re-express thymidine kinase activity following 5-azacytidine treatment?
Moore MM; Applegate ML; Hozier JC
Mutat Res; 1988 Feb; 207(2):77-82. PubMed ID: 2448615
[TBL] [Abstract][Full Text] [Related]
19. Whole genome sequencing analysis of small and large colony mutants from the mouse lymphoma assay.
Guo X; Pan B; Seo JE; Chen Y; Yan J; Mei N; Chen T
Arch Toxicol; 2018 Dec; 92(12):3585-3595. PubMed ID: 30328498
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of mutants at the APRT locus in the L-5178Y TK+/TK- mouse lymphoma cell line.
Paeratakul U; Taylor MW
Mutat Res; 1986 Mar; 160(1):61-9. PubMed ID: 3951457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
